Checkmate Pharmaceuticals, Inc.: operating_income

Value{"amount": -15886000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Period2022-01-01 – 2022-03-31
Statuscurrent
EntityCheckmate Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-22-148774 · Open the official SEC filing →
Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001651431/operating-income/2022-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/b1bc2fc6-7dee-41a0-9932-b28b31e2c2d9

History

From the Record